BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16007029)

  • 1. [The use of esmolol in patients with myocardial infarction complicated with acute left ventricular failure].
    Tereshchenko SN; Kositsyna IV; Dzhaiani NA; Golubev AV; Kochetov AG
    Kardiologiia; 2005; 45(6):19-22. PubMed ID: 16007029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carvedilol saves lives--new data from landmark trials prove survival benefits in heart failure and post myocardial infarction.
    Cardiovasc J S Afr; 2001; 12(2):122-3. PubMed ID: 11474697
    [No Abstract]   [Full Text] [Related]  

  • 3. Lethal outcomes in patients with symptomatic heart failure developed after Q-wave myocardial infarction.
    Zaliūnas R; Babarskiene MR; Kavoliūniene A; Slapikiene B; Luksiene D; Slapikas R; Vencloviene J
    Medicina (Kaunas); 2004; 40(2):141-8. PubMed ID: 15007273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous esmolol is well tolerated in elderly patients with heart failure in the early phase of non-ST elevation myocardial infarction.
    Koutouzis M; Nikolidakis S; Grigoriadis A; Koutsogeorgis D; Kyriakides ZS
    Drugs Aging; 2006; 23(8):673-80. PubMed ID: 16964989
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety of esmolol in patients with acute myocardial infarction treated with thrombolytic therapy who had relative contraindications to beta-blocker therapy.
    Mooss AN; Hilleman DE; Mohiuddin SM; Hunter CB
    Ann Pharmacother; 1994 Jun; 28(6):701-3. PubMed ID: 7919552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The incomplete bucindolol evaluation in acute myocardial infarction Trial (BEAT).
    Torp-Pedersen C; Køber L; Ball S; Hall A; Brendorp B; Ottesen M; Berning J; Jensen G; Hampton J; Zilles P; Eberle S; Carlsen J
    Eur J Heart Fail; 2002 Aug; 4(4):495-9. PubMed ID: 12167390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta blocker therapy after acute myocardial infarction in patients with heart failure and systolic dysfunction.
    Thattassery E; Gheorghiade M
    Heart Fail Rev; 2004 Apr; 9(2):107-13. PubMed ID: 15516858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Variability of heart rate in postmyocardial infarction patients: clinical implications, problems and prospects].
    Popov VV; Kopitsa NP; Oparin AL
    Klin Med (Mosk); 1998; 76(2):15-9. PubMed ID: 9553353
    [No Abstract]   [Full Text] [Related]  

  • 9. Fatal myocardial rupture after acute myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: the VALsartan In Acute myocardial iNfarcTion Trial (VALIANT).
    Shamshad F; Kenchaiah S; Finn PV; Soler-Soler J; McMurray JJ; Velazquez EJ; Maggioni AP; Califf RM; Swedberg K; Kober L; Belenkov Y; Varshavsky S; Pfeffer MA; Solomon SD;
    Am Heart J; 2010 Jul; 160(1):145-51. PubMed ID: 20598985
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart failure complicating acute myocardial infarction.
    Aronow WS
    Clin Geriatr Med; 2000 Aug; 16(3):535-48. PubMed ID: 10918646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of beta-blockers during and after myocardial infarction.
    Aronow WS
    Compr Ther; 1998; 24(6-7):327-31. PubMed ID: 9669097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New evidence from the CAPRICORN Trial: the role of carvedilol in high-risk, post-myocardial infarction patients.
    Sackner-Bernstein JD
    Rev Cardiovasc Med; 2003; 4 Suppl 3():S25-9. PubMed ID: 14564231
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carvedilol: use in chronic heart failure.
    Doughty RN; White HD
    Expert Rev Cardiovasc Ther; 2007 Jan; 5(1):21-31. PubMed ID: 17187454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on pharmacological advances.
    Fonarow G
    J Invasive Cardiol; 2004 Sep; 16 Suppl E():2E-6E. PubMed ID: 23573649
    [No Abstract]   [Full Text] [Related]  

  • 15. How should age affect management of acute myocardial infarction? A prospective cohort study.
    Barakat K; Wilkinson P; Deaner A; Fluck D; Ranjadayalan K; Timmis A
    Lancet; 1999 Mar; 353(9157):955-9. PubMed ID: 10459903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of carvedilol on diastolic function in patients with diastolic heart failure and preserved systolic function. Results of the Swedish Doppler-echocardiographic study (SWEDIC).
    Bergström A; Andersson B; Edner M; Nylander E; Persson H; Dahlström U
    Eur J Heart Fail; 2004 Jun; 6(4):453-61. PubMed ID: 15182771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Heart failure after acute myocardial infarct. Early aldosterone blockade increases survival rate].
    MMW Fortschr Med; 2005 Jul; 147(27-28):44. PubMed ID: 16041942
    [No Abstract]   [Full Text] [Related]  

  • 18. [Neurohumoral systems escape control. Heart failure symptoms even once--long-term high risk prognosis].
    MMW Fortschr Med; 2005 Jul; 147(27-28):45. PubMed ID: 16041943
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiac remodeling in coronary artery disease.
    Sharpe N
    Am J Cardiol; 2004 May; 93(9A):17B-20B. PubMed ID: 15144932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Esmolol in acute ischemic syndromes.
    Mitchell RG; Stoddard MF; Ben-Yehuda O; Aggarwal KB; Allenby KS; Trillo RA; Loyd R; Chang CT; Labovitz AJ
    Am Heart J; 2002 Nov; 144(5):E9. PubMed ID: 12422138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.